News room
TechnoPhage Announces Identification of a New Antibody with Therapeutic Potential for COVID-19
We are proud to announce that a potential new therapeutic antibody for the treatment of COVID-19 has been identified. The candidate antibody was...
Technophage creates LX Bio: a new company to ensure the industrialization of biologics
Technophage’s plans for the next few years have been revealed in a brand new article in Portuguese Weekly Journal “Expresso”. The biopharma is...
Another take on TP-102 Phase I/IIa Clinical Trial by Jornal Expresso
During the development of TP-102 a lot of journals published pieces describing this great Technophage's milestone. This year, Jornal Expresso,...
Technophage granted with the ‘COTEC Innovative Status 2021’
Technophage is proud to announce that it has recently been granted with the 'COTEC Innovative Status 2021'. COTEC Portugal is the main Portuguese...
Technophage’s efforts to tackle COVID-19 in 2021
During this last year, Technophage has been dedicated to the development of a new biologic product for COVID-19. The company has been working...